Pnc Financial Services Group, Inc. Cytosorbents Corp Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 31 shares of CTSO stock, worth $35. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 31
-0.0%
Holding current value
$35
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.56 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.2 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.24 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.93 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.44 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $50.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...